Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Symptomatic systolic ventricular failure.

N Sharpe1

  • 1Department of Medicine, University of Auckland, School of Medicine, Auckland, New Zealand.

Current Cardiology Reports
|September 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epoprostenol increased mortality in patients with severe CHF.

Evidence-based cardiovascular medicine·2005
Same author

Uptake of self-management strategies in a heart failure management programme.

European journal of heart failure·2003
Same author

Factors influencing the length of hospital stay of patients with heart failure.

European journal of heart failure·2003
Same author

Matching the standards of clinical trial evidence with application in practice.

International journal of clinical practice·2003
Same author

Optimization of ACE inhibitor therapy in heart failure.

European heart journal·2002
Same author

The effects of intensive glycaemic control on body composition in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2002
Same journal

Diagnostic Tests for Stage B Heart Failure.

Current cardiology reports·2026
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
Same journal

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
See all related articles

Advances in heart failure management, driven by research, emphasize evidence-based pharmacological treatments. Guidelines now focus on large-scale mortality data and individualized patient care for optimal outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Research

Background:

  • Significant progress in heart failure (HF) management over 20-30 years.
  • Improved understanding of HF pathophysiology, assessment methods, and drug treatments.
  • Shift towards earlier intervention and evidence-based management approaches.

Purpose of the Study:

  • To review randomized controlled clinical trial evidence for pharmacological treatment of congestive heart failure.
  • To highlight the evolution of clinical trial standards towards mortality data.
  • To emphasize the importance of pharmacological therapy within a comprehensive management strategy.

Main Methods:

  • Focus on randomized controlled clinical trials (RCTs) for pharmacological interventions in heart failure.

Related Experiment Videos

  • Analysis of evidence regarding treatment effects on short-term outcomes versus long-term survival.
  • Inclusion of data from large-scale mortality trials.

    • Main Results:

    • Earlier trials used varied endpoints; current standards demand robust mortality data.
    • Some pharmacological agents show improved short-term outcomes but may negatively impact survival.
    • Evidence supports a comprehensive approach including diagnosis, cause correction, and pharmacological treatment.

    Conclusions:

    • Pharmacological treatment is central to heart failure management, supported by extensive clinical trial evidence.
    • Patient education, counseling, and follow-up are crucial complements to medication.
    • Optimal long-term outcomes require adherence to evidence-based guidelines and personalized care.